Corcept Therapeutics CORT Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Corcept Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValueOutstanding.
The official record: Corcept Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Corcept Therapeutics's common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Corcept Therapeutics's common stock?
- Corcept Therapeutics (CORT) reported common stock of $141K in Q1 2026.
- How has Corcept Therapeutics's common stock changed year-over-year?
- Corcept Therapeutics's common stock increased by 2.9% year-over-year, from $137K to $141K.
- What is the long-term trend for Corcept Therapeutics's common stock?
- Over 5 years (2020 to 2025), Corcept Therapeutics's common stock has grown at a 2.8% compound annual growth rate (CAGR), from $122K to $140K.
- What does common stock mean?
- The total par value of all common shares issued by the company.
- How do you interpret common stock?
- An increase indicates new share issuance, while a decrease is rare and typically results from share cancellations.
- How does common stock compare across companies?
- Standard across all public companies, though par values are often nominal.